Physics-based technologies to study biological systems and to diagnose and treat disease.
Esteya electronic brachytherapy is a form of high dose rate (HDR) brachytherapy that brings an electronic brachytherapy source in close proximity to the cancerous site. Its direct delivery enables Esteya to focus more therapeutic radiation on the disease target and to minimize radiation to surrounding tissues and organs.
Hall Scientific is pleased to provide the latest in MRI teaching instruments, the Terranova-MRI is the ideal system for hands-on NMR and MRI learning. The Terranova-MRI uses the Earth’s magnetic field as the primary field, for an MRI imaging system that is affordable, compact, lightweight and safe.
Clinical applications and research advances
Norbert Ludwig, Managing Director for Sales and Marketing at Physik Instrumente (PI) GmbH has been appointed as further managing director at PI miCos GmbH.
Webinar presented by Hazel Rodgers, Deputy Head of Radiotherapy, St James’s Institute of Oncology, Leeds (UK).
The moment Megan Lavelle saw the device, she knew it would change her daughter’s life.
CRAIC Technologies is a global technology leader focused microscopy, microimaging and microspectroscopy in the UV, visible and near-infrared regions. Sub-micron areas can be measured by absorbance, reflectance, fluorescence or Raman microspectra.
Qioptiq is proud to launch the NEW iFLEX-iRIS™ series of miniaturized lasers at the Laser World of Photonics, Munich exhibition. The iFLEX-iRIS laser is created to meet our customers’ need for ever smaller laser systems that have high performance.
UV-visible-NIR, Fluorescence and Raman Microspectroscopy With the New 20/30 PV™ from CRAIC Technologies
San Dimas, CA (April 2, 2013)— CRAIC Technologies, the worlds leading innovator of UV-visible-NIR microanalysis solutions, is proud to introduce the 20/30 PV™ microspectrophotometer.
2 Day Workshops in Dallas/Fort Worth Dedicated to Fluorescence Techniques.
The medicalphysicsweb reviews - 2013 download
Download all medicalphysicsweb reviews published in 2013 here
OXXIUS a french growing company, develops and manufactures low noise and SLM DPSS ...
Medtronic Announces CE Mark and European Launch of First Implantable Cardioverter-Defibrillator System to Allow for Full-Body MRI Scans
Evera MRI(TM) ICD System Is First to Combine Proven Treatment Performance, Increased Longevity, Improved Comfort with Full-Body MRI Access.
IBA Delivers Europe’s First Proteus®ONE Proton Therapy Solution to Centre Antoine Lacassagne, Nice, France
IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has shipped and delivered Proteus®ONE*’s unique compact superconducting proton therapy accelerator to the Centre Antoine Lacassagne in Nice, France.
The American Association for Cancer Research (AACR) and the European Society for Radiotherapy & Oncology (ESTRO) will provide the ideal platform for Xstrahl to publically launch Muriplan, the new Pre-Clinical Treatment Planning System for the Xstrahl Small Animal Radiation Research Platform (SARRP).
Texas Research Associate and Professor Collaborate on Research Session.
Le Bonheur neurosurgeons complete first cases using MR-safe headrest designed specifically for intraoperative imaging in VISIUS Surgical Theatre.
Frederic Moll, M.D., a serial medical device entrepreneur, will kick off the 4th International Symposium on Focused Ultrasound in October 2014 with a keynote presentation titled, “Developing a New, Disruptive Therapeutic Modality: From Laboratory Research Tool to Standard of Care.”
Session Uncovers Latest Findings on Low-Level Laser Therapy and Non-Invasive Treatments.
FDA Approves Piramal Imaging’s NeuraceqTM (florbetaben F18 injection) for PET Imaging of Beta-Amyloid Neuritic Plaques in the Brain
Piramal Imaging today announced that the U.S. Food and Drug Administration (FDA) has approved Neuraceq™. This approval comes only four weeks after receiving marketing authorization for Neuraceq™ from the European Commission.